These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 23209564)

  • 1. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease.
    Erickson AR; Cantarel BL; Lamendella R; Darzi Y; Mongodin EF; Pan C; Shah M; Halfvarson J; Tysk C; Henrissat B; Raes J; Verberkmoes NC; Fraser CM; Hettich RL; Jansson JK
    PLoS One; 2012; 7(11):e49138. PubMed ID: 23209564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location-specific signatures of Crohn's disease at a multi-omics scale.
    Gonzalez CG; Mills RH; Zhu Q; Sauceda C; Knight R; Dulai PS; Gonzalez DJ
    Microbiome; 2022 Aug; 10(1):133. PubMed ID: 35999575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.
    Baumgart M; Dogan B; Rishniw M; Weitzman G; Bosworth B; Yantiss R; Orsi RH; Wiedmann M; McDonough P; Kim SG; Berg D; Schukken Y; Scherl E; Simpson KW
    ISME J; 2007 Sep; 1(5):403-18. PubMed ID: 18043660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.
    Nguyen HT; Dalmasso G; Müller S; Carrière J; Seibold F; Darfeuille-Michaud A
    Gastroenterology; 2014 Feb; 146(2):508-19. PubMed ID: 24148619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum.
    Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A
    J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment-naive microbiome in new-onset Crohn's disease.
    Gevers D; Kugathasan S; Denson LA; Vázquez-Baeza Y; Van Treuren W; Ren B; Schwager E; Knights D; Song SJ; Yassour M; Morgan XC; Kostic AD; Luo C; González A; McDonald D; Haberman Y; Walters T; Baker S; Rosh J; Stephens M; Heyman M; Markowitz J; Baldassano R; Griffiths A; Sylvester F; Mack D; Kim S; Crandall W; Hyams J; Huttenhower C; Knight R; Xavier RJ
    Cell Host Microbe; 2014 Mar; 15(3):382-392. PubMed ID: 24629344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Adherent-invasive
    Zhilu X; Xiangqian D; Keli Y; Caroline C; Jingwan Z; Yu L; Tao Z; Cheung CL; Yang S; Fengrui Z; Kl CF; Jy SJ; Jun Y; Anthony B; Nicolas B; Jean-Frédéric C; Sunny Hei W; Yinglei M; Siew C N
    Gut Microbes; 2021; 13(1):1994833. PubMed ID: 34812117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease.
    Ng SC; Benjamin JL; McCarthy NE; Hedin CR; Koutsoumpas A; Plamondon S; Price CL; Hart AL; Kamm MA; Forbes A; Knight SC; Lindsay JO; Whelan K; Stagg AJ
    Inflamm Bowel Dis; 2011 Oct; 17(10):2027-37. PubMed ID: 21910165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential and active functions in the gut microbiota of a healthy human cohort.
    Tanca A; Abbondio M; Palomba A; Fraumene C; Manghina V; Cucca F; Fiorillo E; Uzzau S
    Microbiome; 2017 Jul; 5(1):79. PubMed ID: 28709472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.
    Willing BP; Dicksved J; Halfvarson J; Andersson AF; Lucio M; Zheng Z; Järnerot G; Tysk C; Jansson JK; Engstrand L
    Gastroenterology; 2010 Dec; 139(6):1844-1854.e1. PubMed ID: 20816835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.
    Davenport M; Poles J; Leung JM; Wolff MJ; Abidi WM; Ullman T; Mayer L; Cho I; Loke P
    Inflamm Bowel Dis; 2014 Apr; 20(4):723-31. PubMed ID: 24583479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut dysbiosis and paediatric Crohn's disease.
    Brusaferro A; Cavalli E; Farinelli E; Cozzali R; Principi N; Esposito S
    J Infect; 2019 Jan; 78(1):1-7. PubMed ID: 30336176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod2 is essential for temporal development of intestinal microbial communities.
    Rehman A; Sina C; Gavrilova O; Häsler R; Ott S; Baines JF; Schreiber S; Rosenstiel P
    Gut; 2011 Oct; 60(10):1354-62. PubMed ID: 21421666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses.
    Tyakht AV; Manolov AI; Kanygina AV; Ischenko DS; Kovarsky BA; Popenko AS; Pavlenko AV; Elizarova AV; Rakitina DV; Baikova JP; Ladygina VG; Kostryukova ES; Karpova IY; Semashko TA; Larin AK; Grigoryeva TV; Sinyagina MN; Malanin SY; Shcherbakov PL; Kharitonova AY; Khalif IL; Shapina MV; Maev IV; Andreev DN; Belousova EA; Buzunova YM; Alexeev DG; Govorun VM
    BMC Genomics; 2018 Dec; 19(1):968. PubMed ID: 30587114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's Disease Differentially Affects Region-Specific Composition and Aerotolerance Profiles of Mucosally Adherent Bacteria.
    Shahir NM; Wang JR; Wolber EA; Schaner MS; Frank DN; Ir D; Robertson CE; Chaumont N; Sadiq TS; Koruda MJ; Rahbar R; Nix BD; Newberry RD; Sartor RB; Sheikh SZ; Furey TS
    Inflamm Bowel Dis; 2020 Nov; 26(12):1843-1855. PubMed ID: 32469069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.